Transition Bio
Transition Bio provides condensate technology for drug discovery and diagnostics.
Transition Bio is active in the biotechnology, health care, health diagnostics, medical space based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2020.
The company sits in the biotechnology, health care, health diagnostics, medical segment, where it competes on its core product or service.
Its base of operations is Greater Boston Area, East Coast, New England, Northeastern US.
The company is listed at the Series_A stage of development.
The company reports a headcount in the c_00011_00050 range.
It has disclosed roughly $50M in funding.
| Sector | Biotechnology, Health Care, Health Diagnostics, Medical |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $50,000,000 |
Website: www.transitionbio.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account